Generate a tailored SOP for Dr. Margie Moczygemba. Improve your application with a focused, well-structured draft.
Margie Moczygemba is an Associate Professor at Texas A&M University, specializing in molecular immunology with a focus on allergic inflammation and eosinophil biology. Her research aims to develop interventional strategies to block allergic responses, particularly by understanding the role of cytokine signaling in eosinophil activation, primarily via interleukin-5 (IL-5). Prof. Moczygemba's laboratory employs a mix of cellular, immunological, and biochemical techniques to uncover novel targets that can modulate inflammatory signals triggered by eosinophils. A significant aspect of her work includes molecular characterization of IL-5 receptor ubiquitination, particularly concerning the common beta chain, which has critical implications for receptor regulation. Her collaborations with MD Anderson Cancer Center involve harnessing lung innate immunity through aerosolized TLR ligands to modulate immune responses in asthma. Prof. Moczygemba's extensive publication record demonstrates her contributions to the understanding of therapeutic strategies in allergic conditions and eosinophilic disorders, making her a prominent figure in her field.
Texas A&M University • Houston, TX
Directs HT Flow Cytometry Analysis & Cell Sorting Core Facility and advises Dean of Internal Affairs.
Department: Department of Communication and Journalism. Ph.D. program only currently admitting. GRE is test-optional.